Riskpilot← Back to searchSign inGet full accessArex Advisor AB
ABActiveOrg 5592354905Sveavägen 9Business and other management consultancy activities · NACE 7020Est. 202032 employees
Revenue 2024
SEK 54,9M
+10% vs 2023
EBITDA margin
7.4%
-50% vs 2023
Equity ratio
17.9%
Financial strength
Net profit 2024
SEK 2,8M
-55% vs 2023
| Revenue | SEK 54,9M | +10% |
| EBITDA | SEK 4M | -50% |
| Net profit | SEK 2,8M | -55% |
| Total assets | SEK 15,7M | -7% |
| Equity | SEK 2,8M | -54% |
| Employees | 32 | — |
Legal name
Arex Advisor AB
Org number
5592354905
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
7 januari 2020
Share capital
SEK 54 467
Employees
32 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Thunell, Carl Staffan Thunell, Linda Birgitta
Company purpose
Bolaget ska, direkt eller via dotterbolag, tillhandahålla konsulttjänster till läkemedels-, medicinteknik- och hälsovårdsindustrin, samt därmed förenlig verksamhet.
Address
Sveavägen 9
Phone
+46851934500
Email
staffan.thunell@arexadvisor.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 266 | 25 885 | 37 492 | 49 733 | 54 900 |
| Staff expenses | — | — | −20 240 | −26 465 | −35 385 |
| EBITDA | −4 643 | −313 | 4 634 | 8 059 | 4 043 |
| Depreciation & amort. | −33 | −164 | −211 | −266 | −371 |
| EBIT | −4 676 | −477 | 4 423 | 7 793 | 3 672 |
| Net financials | −1 | −1 | −1 | −199 | −142 |
| Profit before tax | −4 677 | −477 | 4 421 | 7 594 | 3 530 |
| Tax | −0 | −0 | — | −1 515 | −777 |
| Net profit | −4 677 | −477 | 4 421 | 6 079 | 2 752 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 627 | 10 627 | 10 961 | 16 905 | 15 672 |
| Equity | 525 | 48 | 4 493 | 6 128 | 2 807 |
| Long-term debt | 0 | 400 | 0 | — | 2 000 |
| Short-term debt | 3 102 | 10 179 | 6 468 | 10 777 | 10 865 |
| Total debt | 3 102 | 10 579 | 6 468 | 10 777 | 12 865 |
EBITDA margin
7.4%
This company
15.8%
Market median
-53% vs market
20202024
Equity ratio
17.9%
This company
38.2%
Market median
-53% vs market
20202024
Return on equity
98.1%
This company
18.4%
Market median
+433% vs market
20202024
Net profit margin
5.0%
This company
8.1%
Market median
-38% vs market
20202024
Asset turnover
3.50×
This company
1.12×
Market median
+212% vs market
20202024
Debt / equity
4.58×
This company
0.62×
Market median
-639% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LB Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
EA Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Arex Intressenter AB | Company | 88.0% | 88.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nevada Pharma AB
Arex Advisor AB Board members of Arex Advisor AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linda Birgitta Thunell | Chief Executive Officer | 0 companies |
| Erik Adrian Emilsson | Chief Auditor | 0 companies |
| Erik Thomas Hedner | Board of Directors | 0 companies |
| Eva Lovisa Kristina Rosenquist | Board of Directors | 0 companies |
| Carl Staffan Thunell | Chairman | 0 companies |